A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.
about
A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@en
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@nl
type
label
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@en
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@nl
prefLabel
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@en
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@nl
P2093
P2860
P356
P1476
A FCGR3A Polymorphism Predicts ...... atients Treated With Anti-TNF.
@en
P2093
Daniel Torres-Moreno
Guadalupe Ruiz-Merino
José Pedregosa
Juan Antonio Vílchez
María Sergia García-Simón
Patricia Romero-Cara
Senador Morán-Sanchez
P2860
P356
10.7150/IJMS.22812
P407
P577
2018-01-01T00:00:00Z